Press Releases on August 10, 2020 - EIN Presswire - Press Release Distribution Service

Published on August 10, 2020 - 11:00 GMT

NXT Energy Solutions Announces Release Date for Its Second Quarter 2020 Results and Conference Call

CALGARY, Alberta, Aug. 10, 2020 (GLOBE NEWSWIRE) -- NXT Energy Solutions Inc. (“NXT” or the "Company") (TSX:SFD; OTC QB:NSFDF) announces it will release its second quarter 2020 financial and operating results for the quarter ended June 30, 2020, …

Distribution channels: Culture, Society & Lifestyle, Energy Industry ...

Published on August 10, 2020 - 11:00 GMT

Corvus Gold to Trade on the Nasdaq, Obtains Full Senior US Listing Under Symbol KOR

VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Corvus Gold Inc. (“Corvus” or the “Company”) - (TSX: KOR, OTCQX: CORVF) announces that it has received approval to up-list to the Nasdaq Capital Markets and will begin trading under the symbol …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on August 10, 2020 - 11:00 GMT

First Advantage Named Best Tenant Screening Service of 2020 by Investopedia

ATLANTA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- First Advantage, the global leader in background check and drug screening solutions, has been recognized by Investopedia as the “Best Overall” Tenant Screening Service of 2020. First Advantage Resident Screening …

Distribution channels: Media, Advertising & PR ...

Published on August 10, 2020 - 11:00 GMT

New Pacific Announces Graduation to TSX

VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) -- New Pacific Metals Corp. (TSX-V: NUAG) (OTCQX: NUPMF) ("New Pacific" or the "Company") is pleased to announce that it has received final approval for the listing of its …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on August 10, 2020 - 11:00 GMT

Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations

EWING, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Tram Bui as Vice President of Corporate Communications and Investor Relations. Ms. …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 10, 2020 - 11:00 GMT

Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates

Plans to present three-year Phase 1b results of VY-AADC (NBIb-1817) in patients with Parkinson’s disease at the Movement Disorder Society (MDS) Virtual Congress 2020 Expects screening and enrollment in RESTORE-1 trial of VY-AADC …

Distribution channels:

Published on August 10, 2020 - 11:00 GMT

Kamada Announces Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Derived Immunoglobulin (IgG) Product as ...

Study Participants are Hospitalized, Non-ventilated COVID-19 Patients with Pneumonia Encouraging Neutralization Activity Observed with Virus Neutralization Assay Pre-IND Meeting with U.S. FDA to be Conducted in Current Quarter, with U.S. Clinical …

Distribution channels:

Published on August 10, 2020 - 11:00 GMT

Exterran Corporation Announces Second Quarter 2020 Results

Strong Operational Performance despite Challenging Environment Company to Exit the U.S. Compression Fabrication Business in the Fourth Quarter HOUSTON, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Exterran Corporation (NYSE: EXTN) (“Exterran” or the “Company”) today …

Distribution channels: Business & Economy, Energy Industry ...

Published on August 10, 2020 - 11:00 GMT

Morphic Announces Corporate Highlights and Second Quarter 2020 Financial Results

Company’s first IND accepted by FDA for MORF-057 in IBD Phase 1 study expected to begin in third-quarter 2020 Positive data presented at DDW 2020 further support MORF-057 preclinical profile WALTHAM, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Morphic …

Distribution channels:

Published on August 10, 2020 - 11:00 GMT

Axsome Therapeutics Announces Further Progress in AXS-05 Depression Clinical Program

Enrollment complete in the COMET Phase 3 long-term safety trial of AXS-05 in MDD; NDA filing on track for 4Q 2020 Results from three Phase 2 open-label efficacy trials of AXS-05 in TRD, antidepressant unresponsive MDD, and suicidal ideation, expected in 4Q …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 10, 2020 - 11:00 GMT

Chimerix Reports Second Quarter 2020 Financial Results and Provides Operational Update

– Completion of BCV NDA Rolling Submission Planned for Third Quarter 2020 – – Currently Enrolling Phase 2/3 Study of DSTAT in Patients with COVID-19; Phase 2 Enrollment Completion Expected in Fourth Quarter – – Startup Activities for DSTAT Phase 3 AML …

Distribution channels:

Published on August 10, 2020 - 11:00 GMT

Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results

-- Interim Phase 2 Vivacity-MG results met primary endpoints, demonstrating nipocalimab was well-tolerated and achieved rapid and durable responses with significant correlation (p<0.0001) between IgG reduction and MG-ADL clinical benefit in MG; full …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 10, 2020 - 11:00 GMT

Synchronoss Technologies Announces Second Quarter 2020 Results: Revenue $76.5 million, Adjusted EBITDA $11.5 million, Adjusted ...

BRIDGEWATER, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (NASDAQ: SNCR), a global leader and innovator in cloud, messaging, digital and IoT platforms and products, today announced financial results for its second quarter ended …

Distribution channels: Business & Economy, IT Industry ...

Published on August 10, 2020 - 11:00 GMT

Akoustis to Webcast Investor Update Call on August 24th at 8:00 a.m. ET

Charlotte, N.C., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Akoustis, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, …

Distribution channels: Media, Advertising & PR, Technology ...

Published on August 10, 2020 - 11:00 GMT

Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates

Galafold 2Q2020 Revenue of $62.4 Million, On-Track to Achieve 2020 Revenue Guidance of $250M-$260M AT-GAA Phase 3 PROPEL Study Readout and Rolling BLA Submission to U.S. FDA on Schedule Advancing Industry-Leading Rare Disease Gene Therapy Portfolio Path …

Distribution channels:

Published on August 10, 2020 - 11:00 GMT

$12 million Share Placement to accelerate exploration

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce a two tranche placement to raise $12.0 million (Placement). Highlights Well supported with the introduction of several new …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on August 10, 2020 - 11:00 GMT

Recro Reports Second Quarter 2020 Financial Results

Launches Clinical Trial Materials Business and Secures New Customers Company to Host Conference Call Today at 8:00 a.m. ET MALVERN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 10, 2020 - 11:00 GMT

FangDD to Announce Second Quarter 2020 Financial Results on August 13, 2020

SHENZHEN, China, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a leading property technology company in China, today announced that it plans to release its second quarter 2020 financial results after …

Distribution channels: Culture, Society & Lifestyle, Real Estate & Property Management ...

Published on August 10, 2020 - 11:00 GMT

Pluristem Expands its COVID-19 Program to Europe, Receives PEI Clearance to Commence Phase II Study in Germany

HAIFA, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today that Germany’s health regulatory …

Distribution channels: Media, Advertising & PR, Technology ...

Published on August 10, 2020 - 11:00 GMT

TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results

NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended June 30, 2020 and recent company developments. Michael S. Weiss, the Company's Executive Chairman and …

Distribution channels: